Centrient Pharmaceuticals India Private Limited — Nawashahr
USFDA inspection record for FEI 3004497364, Nawashahr, India.
OAI
Latest classification
2
Inspections on record
0
Form 483 observations on record
History (newest first)
Inspections
27 Jan 2026
OAI — Official action indicated
Drug Quality Assurance · Drugs · FY2026
Source: FDA Data Dashboard ↗
01 Jul 2022
OAI — Official action indicated
Drug Quality Assurance · Drugs · FY2022
Source: FDA Data Dashboard ↗
FDA compliance actions
| Date | Action | Product type |
|---|---|---|
| 07 Dec 2022 | Warning Letter | Drugs |
📎 Cite this data: Source: PharmaRoz, FDA inspection record for FEI 3004497364, updated 12 Nov 2026